Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Unsuccessful developing brain cancer drugs in the U.S. 1998-2014

Number of unsuccessful brain cancer drugs in development in the United States from 1998 to 2014

by Statista Research Department, last edited Oct 23, 2014
Unsuccessful developing brain cancer drugs in the U.S. 1998-2014 This statistic shows the number of unsuccessful brain cancer drugs in development in the United States from 1998 to 2014. In 2011, there were six unsuccessfully developed brain cancer drugs. Since 1998, there have been 75 total medicines being developed for brain cancer that were discontinued, suspended, or had no development reported and 3 approved medications.
Show more

Number of unsuccessful brain cancer drugs in development in the United States from 1998 to 2014

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Cancer in Italy"
  • Incidence
The most important statistics
  • Screening
  • Mortality
  • Care and treatments
  • Research and fundraising
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.